Research Triangle Park, NC, January 8, 2013. Marken announced today the completion of its new, expanded pharmaceutical depot in Mexico City. The new state of the art facility is located closer to the Mexico City airport and provides a total of 1300 m² of GMP-compliant space for temperature controlled storage and distribution of clinical trial supplies. The recent expansion was a response to the significant client demand Marken is experiencing within that region.
“We are very pleased to announce the completion of this expansion which is a direct result of an increased demand for our services. In addition, we also enhanced our global project management team with experienced Project Leaders ensuring seamless set-up and coordination of all global clinical trial storage and distribution work. We will continue to push forward in enlarging our network to provide the most efficient and flexible solutions to our clients” said Gerit Offenhauser, Senior Vice President, Clinical Trials Distribution.
Marken’s depots provide secure temperature controlled storage and distribution for pharmaceuticals, biologics, medical devices and diagnostic equipment. The new depot will supplement Marken’s existing network of global depots in Germany, Singapore, USA and Argentina. Marken’s depot network is connected through the Solo platform, a global state-of-the-art, 21 CFR part 11 validated, cloud based inventory management system which tracks dosages at the patient level.
Wes Wheeler, Chief Executive Officer of Marken said, “Today’s completion of our new Mexico depot is another important milestone in our global depot network expansion strategy. Through further continued investment in facilities and technologies, we will continue to ensure that our clients are served with full service, global clinical supply chain solutions and that we provide the highest quality courier and logistics services to our clients.”